Alexander Hardy has been involved in significant stock trading activities that reflect his investment in the company. His insider trading history shows a peak net worth tied to his holdings that reached nearly $39 million back in December 2019. Since...

Alexander Hardy has been involved in significant stock trading activities that reflect his investment in the company. His insider trading history shows a peak net worth tied to his holdings that reached nearly $39 million back in December 2019. Since then, his wealth has seen fluctuations, dipping to around $28.80 million in October 2023 and slightly increasing to about $30.29 million as of September 2023. His vested stock options and restricted stock units are designed to motivate and align his performance with shareholders, and while he just started his role at BioMarin, his past indicates he has been vested in making impactful long-term gains. His holdings are essential not just in terms of financial stability but also for ensuring that his interests align closely with those of the shareholders. This history of stock trading showcases his commitment to the company and industry, utilizing his insights to navigate the complexities of the biotechnology market.